INTRODUCTION

Dyschromatosis symmetrica hereditaria (DSH: MIM#127400)
shows an autosomal-dominant pattern of inheritance with high penetrance. It is characterized by hyperpigmented and hypopigmented macules on the face and dorsal aspects of the extremities that appear in infancy or early childhood . In Asia, the condition occurs predominantly among Japanese and Chinese individuals (Oyama et al., 1999) . Miyamura et al. (2003) have clarified that a heterozygous mutation of the adenosine deaminase acting on RNA 1 (ADAR1 or DSRAD) gene causes DSH in four Japanese DSH families. Subsequently, we reported 16 novel mutations in the ADAR1 gene in Japanese patients with DSH (Suzuki et al., 2005) . On the other hand, 22 novel mutations in the ADAR1 gene have been reported in Chinese and Taiwanese patients with DSH (Chao et al., 2005; Cui et al., 2005; Li et al., 2005a, b; Xing et al., 2005; Liu et al., 2006) , which confirmed that the ADAR1 gene is responsible for DSH not only in Japanese but also in other ethnic groups.
ADAR1 protein catalyzes the deamination of adenosine to inosine in double-stranded RNA substrates (Bass and Weintraub, 1988; Wagner et al., 1989) , which results in the creation of alternative splicing sites or alternations of the codon and thus leads to functional changes in the protein. The ADAR1 gene is expressed ubiquitously, but the target gene(s) in the skin still remain unknown, and also the molecular pathogenesis of DSH has not been clarified yet.
In this study, we report 10 different novel mutations in patients with DSH. Table 1 summarizes the clinical and molecular findings of patients with DSH in this study.
RESULTS AND DISCUSSION
We identified 10 novel heterozygous mutations containing five missense mutations (p.R892L, p.I913R, p.R916Q, p.C1081S, and p.C1169F), four frameshift mutations (p.Q102fsX123, p.T369fsX374, p.S664fsX677, and p.P990fsX1016), and one nonsense mutation (p.K1187X) in 10 patients (Table 1) . One sporadic and five families phenotypically presented typical and strong macules on the dorsal aspects of the hands, feet, lower arms, and lower legs, and freckle-like macules on the face. The other four families showed faint phenotypes. No relationship between the phenotypes and genotypes was detected.
All of the five novel missense mutations identified in this study (Table 1) were located at amino-acid residues conserved among pufferfish, zebrafish, frog, rat, mouse, cow, and human within the deaminase domain of the ADAR1 protein. None of these five missense mutations was found in the blood samples of any of the 100 unrelated, normally pigmented Japanese adults who were surveyed. Thus, we considered that these mutations should be the pathogenic ones with no functional activity.
As shown in Table 1 , all of the four frameshift mutations and one nonsense mutation make a new stop codon after each mutation, and ADAR1 protein synthesis should end there without translating the full deaminase domain located in exons 9-15, which should produce inactive enzymes of ADAR1.
So far, a total of 52 different mutations of the ADAR1 gene have been reported in Japanese, Chinese, and Taiwanese patients with DSH ( Figure 1 ). Thirty-five mutations among the fifty-two mutations (67%) are located within the deaminase domain of the ADAR1 protein. The deaminase domain of the ADAR1 protein is located in the codon from 886 to 1,221, which is approximately 27% of the full length of the ADAR1 protein (Figure 1) . These results suggest that the deaminase domain might be a hot spot for mutations.
Human ADAR1 protein has been reported to include two major forms; one is the IFN-inducible full-length 150-kDa protein (hADAR1-p150) and the other is the constitutively expressed N-terminally truncated 110-kDa protein (hADAR1-p110). The production of the two forms is due to the presence of different promoters (Kawakubo and Samuel, 2000) . The methionine initiation codon for the 1,226-amino-acid open reading frame specifies the hADAR1-p150. On the other hand, the AUG at codon 296 initiates translation of the 931-amino-acid open reading frame encoding the hADAR1-p110. The two mutations of p.Q102fs reported in this study and p.H216fs reported previously (Suzuki et al., 2005) are located at the 5 0 side of codon 296 which is the translation initiation codon for hADAR1-p110 (Figure 1) . Therefore, they must cause frameshift changes in the synthesis of hADAR1-p150, but an effect on the synthesis of p110 protein is not obvious.
Further analysis, such as a stability assay on the p110 mRNA including the mutations, should be carried out for definitive assignment of mutation functionality.
MATERIALS AND METHODS
Subjects
A total of 10 unrelated Japanese patients with DSH and 100 unrelated, normally pigmented Japanese were included in the mutation analysis. One patient (no. 24) with DSH had no family history of the disease and the families of the other patients turned out to have at least one other affected individual in each family (Table 1) . We screened one affected individual of each pedigree for a mutation of the ADAR1 gene. The birthplaces of the patients were scattered around Japan, and no high incidence area for DSH was found. The patients originally consulted us for their skin conditions. The degree of hyper-and hypopigmentation in each patient varied from distinct to indistinct. This study was approved by the Ethics Committee of Nagoya University Graduate School of Medicine. This study was conducted according to the Declaration of Helsinki Principles. Informed written consent was obtained from each patient or from the patient's parents in the case of children.
Mutation detection and conformation
Mutation analysis of the ADAR1 gene was performed as described previously (Suzuki et al., , 2005 . Briefly, genomic DNA was extracted from peripheral blood samples. The mutation screening was carried out with single-strand conformation polymorphism/ heteroduplex analysis and direct sequencing. ADAR1 GenBank sequences used: NM_001111.3 (cDNA).
